Emergent Biosolutions Inc. (EBS)
Emergent BioSolutions Awarded $30 Million Contract Modification forCYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
Emergent BioSolutions Awarded $30 Million Contract Modification forCYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
There are no comments here yet...